Keywords: Mucopolysaccharidosis نوع I; CNS; central nervous system; ERT; Enzyme replacement therapy; HCT; hematopoietic cell transplantation; MPS; Mucopolysaccharidosis; MPS I; Mucopolysaccharidosis Type I; MPS IH; Mucopolysaccharidosis Type IH, Hurler Syndrome; MRI; magnetic resonance imaging
مقالات ISI Mucopolysaccharidosis نوع I (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Mucopolysaccharidosis نوع I; LSD; Newborn screening; Lysosomal storage disorder; Fabry disease; Pompe disease; Gaucher disease; Krabbe disease; Mucopolysaccharidosis type I; Niemann-Pick A/B;
Keywords: Mucopolysaccharidosis نوع I; DBS; Dried blood spot; GAA; Acid α-glucosidase; GBA; Acid β-d-glucosidase; GLA; Acid α-galactosidase; IDUA; Acid α-l-iduronidase; LSD; Lysosomal storage disorder; MPS I; Mucopolysaccharidosis type I; MSPHL; Missouri State Public Health Laboratory; NBS
Keywords: Mucopolysaccharidosis نوع I; DBS; Dried blood spots collected on filter paper; MPS I; Mucopolysaccharidosis type I; MPS VI; Mucopolysaccharosis type VI; LSDs; Lysosomal storage disorders; LC/MS/MS; Liquid chromatography combined with tandem mass spectrometry; GAL; Alpha-galactosidase
Bull's eye maculopathy and subfoveal deposition in two mucopolysaccharidosis type I patients on long-term enzyme replacement therapy
Keywords: Mucopolysaccharidosis نوع I; Enzyme replacement therapy; Scheie; Macula; Mucopolysaccharidosis type I; Iduronidase;
Cathepsin B inhibition attenuates cardiovascular pathology in mucopolysaccharidosis I mice
Keywords: Mucopolysaccharidosis نوع I; Mucopolysaccharidosis type I; Cardiovascular disease; Cathepsin B; Ca-074 Me;
Optimization of alginate microcapsules containing cells overexpressing α-l-iduronidase using Box-Behnken design
Keywords: Mucopolysaccharidosis نوع I; Alginate; Box-Behnken design; Microcapsule; Mucopolysaccharidosis type I; Poly-l-lysine; Recombinant cells;
Intra-articular nonviral gene therapy in mucopolysaccharidosis I mice
Keywords: Mucopolysaccharidosis نوع I; Gene therapy; Intra-articular; Joint; Mucopolysaccharidosis type I; Nanoemulsion; Nonviral vectors;
Gene editing of MPS I human fibroblasts by co-delivery of a CRISPR/Cas9 plasmid and a donor oligonucleotide using nanoemulsions as nonviral carriers
Keywords: Mucopolysaccharidosis نوع I; CRISPR/Cas9; Gene therapy; Gene editing; Mucopolysaccharidosis type I; Nanoemulsion; Nonviral vectors;
In vivo genome editing of mucopolysaccharidosis I mice using the CRISPR/Cas9 system
Keywords: Mucopolysaccharidosis نوع I; CRISPR/Cas; Genome editing; Liposome; Lysosomal storage disease; Mucopolysaccharidosis type I; Nonviral vector;
Immune tolerance induction for laronidase treatment in mucopolysaccharidosis I
Keywords: Mucopolysaccharidosis نوع I; Mucopolysaccharidosis type I; Enzyme replacement therapy; Immune tolerance; Laronidase; Hurler syndrome; Anti-drug antibodies;
Progressive heart disease in mucopolysaccharidosis type I mice may be mediated by increased cathepsin B activity
Keywords: Mucopolysaccharidosis نوع I; Mucopolysaccharidosis type I; Glycosaminoglycan; Cathepsin B; Lysosomal storage disorder; Heart dilatation;
Urinary metabolic phenotyping of mucopolysaccharidosis type I combining untargeted and targeted strategies with data modeling
Keywords: Mucopolysaccharidosis نوع I; IEM; inborn errors of metabolism; LSD; lysosomal storage diseases; MPS; mucopolysaccharidoses; GAGs; glycosaminoglycans; MPS I; mucopolysaccharidosis type I; MPS IT; treated mucopolysaccharidosis type I; UPLC-IM-MS; ultraperformance liquid chromatography-
Mucopolysaccharidosis Type I Newborn Screening: Best Practices for Diagnosis and Management
Keywords: Mucopolysaccharidosis نوع I; CNS; Central nervous system; DBS; Dried blood spot; ERT; Enzyme replacement therapy; GAG; Glycosaminoglycan; HSCT; Hematopoietic stem cell transplantation; IDUA; α-L-iduronidase; MPS; Mucopolysaccharidoses; MPS I; Mucopolysaccharidosis type I; MRI; Magne
Monitoring of dipeptidyl peptidase-IV (DPP-IV) activity in patients with mucopolysaccharidoses types I and II on enzyme replacement therapy - Results of a pilot study
Keywords: Mucopolysaccharidosis نوع I; Mucopolysaccharidosis type I; Mucopolysaccharidosis type II; DPP-IV; Enzyme replacement therapy; Biomarker;
Original ArticlesOutcomes of Long-Term Treatment with Laronidase in Patients with Mucopolysaccharidosis Type I
Keywords: Mucopolysaccharidosis نوع I; MPS I; mucopolysaccharidosis type I; enzyme replacement therapy; laronidase; 6MWT; 6-minute walk test; ERT; Enzyme replacement therapy; FVC; Forced vital capacity; GAG; Glycosaminoglycan; MPS I; Mucopolysaccharidosis type I; uGAG; Urinary glycosaminoglyca
Medical Costs Related to Enzyme Replacement Therapy for Mucopolysaccharidosis Types I, II, and VI in Brazil: A Multicenter Study
Keywords: Mucopolysaccharidosis نوع I; enzyme replacement therapy; health technology assessment; mucopolysaccharidosis type I; mucopolysaccharidosis type II; mucopolysaccharidosis type VI; rare disorders;
Neurocognition across the spectrum of mucopolysaccharidosis type I: Age, severity, and treatment
Keywords: Mucopolysaccharidosis نوع I; Mucopolysaccharidosis Type I; Neurocognition; Genotypes; Neuroimaging;
Genotypic and bioinformatic evaluation of the alpha-l-iduronidase gene and protein in patients with mucopolysaccharidosis type I from Colombia, Ecuador and Peru
Keywords: Mucopolysaccharidosis نوع I; Mucopolysaccharidosis type I; α-l-Iduronidase; Hurler; Scheie; Mutational analysis; Bioinformatic model
Characterization of α-l-Iduronidase (Aldurazyme®) and its complexes
Keywords: Mucopolysaccharidosis نوع I; IDUA, Alpha-l-Iduronidase; GAGs, glycosaminoglycans; 2-DE, Two-dimensional gel electrophoresis; DDM, n-dodecyl β-d-maltosidaseα-l-Iduronidase; Mass spectrometry; Mucopolysaccharide; Mucopolysaccharidosis type I; Post-translational modification; Glycosylat
Experiences of parents and patients with the timing of Mucopolysaccharidosis type I (MPS I) diagnoses and its relevance to the ethical debate on newborn screening
Keywords: Mucopolysaccharidosis نوع I; Mucopolysaccharidosis type I; Lysosomal storage disease; Newborn screening; Qualitative research; Delayed diagnosis;
Intraperitoneal implant of recombinant encapsulated cells overexpressing alpha-l-iduronidase partially corrects visceral pathology in mucopolysaccharidosis type I mice
Keywords: Mucopolysaccharidosis نوع I; alginate microcapsules; cell encapsulation; cell therapy; gene therapy; Hurler syndrome; mucopolysaccharidosis type I
Educational Corner of the Issue
Keywords: Mucopolysaccharidosis نوع I; Mucopolysaccharidosis type I; MPS I; Lysosomal enzyme; Lysosomal storage disorder; Facial dysmorphism;
Cervical pachymeningeal hypertrophy as the initial and cardinal manifestation of mucopolysaccharidosis type I in monozygotic twins with a novel mutation in the alpha-l-iduronidase gene
Keywords: Mucopolysaccharidosis نوع I; Mucopolysaccharidosis type I; Pachymeningeal hypertrophy; Cervical myelopathy; Monozygotic twin; Alpha-l-iduronidase gene mutation
A novel mucopolysaccharidosis type I associated splice site mutation and IDUA splice variants
Keywords: Mucopolysaccharidosis نوع I; Cq; quantification cycles; DS; dermatan sulfate; ERT; enzyme replacement therapy; GAGs; glycosaminoglycans; HSCT; hematopoietic stem cell transplantation; HS; heparan sulfate; IDUA; α-l-iduronidase; MPS I; mucopolysaccharidosis type I; PTC; premature ter
Rapid and accurate denaturating high performance liquid chromatography protocol for the detection of α-l-iduronidase mutations causing mucopolysaccharidosis type I
Keywords: Mucopolysaccharidosis نوع I; Mucopolysaccharidosis type I; MPS I; α-l-Iduronidase; IDUA; dHPLC
Mucopolysaccharidoses type I and IVA: Clinical features and consanguinity in Tunisia
Keywords: Mucopolysaccharidosis نوع I; Consanguinity; Clinical and molecular analyses; First cousin degree; Mucopolysaccharidosis type I; Mucopolysaccharidosis type IVA; Tunisian familiesConsanguinité; Analyses cliniques et moléculaires; Cousins germains; Mucopolysaccharidose de type I; Mucopo
Characterization of Surgical Procedures in Patients with Mucopolysaccharidosis Type I: Findings from the MPS I Registry
Keywords: Mucopolysaccharidosis نوع I; CNS; Central nervous system; ERT; Enzyme replacement therapy; HSCT; Hematopoietic stem cell transplantation; MPS I; Mucopolysaccharidosis type I;
Mutational and oxidative stress analysis in patients with mucopolysaccharidosis type I undergoing enzyme replacement therapy
Keywords: Mucopolysaccharidosis نوع I; Mucopolysaccharidosis type I; α-l-iduronidase; IDUA gene; Enzyme replacement therapy; Oxidative stress
Long-term memory for aversive training is impaired in Idua−/− mice, a genetic model of mucopolysaccharidosis type I
Keywords: Mucopolysaccharidosis نوع I; Mucopolysaccharidosis type I; Lysosomal storage disease; MPS mouse model; Neural plasticity; Memory; Behavior